Cargando…
Loss of 5-hydroxymethylcytosine as a Poor Prognostic Factor for Primary Testicular Diffuse Large B-cell Lymphoma
Background: 5-Hydroxymethylcytosine (5-hmC), a stable epigenetic marker, is closely related to tumor staging, recurrence and survival, but the prognostic value of 5-hmC in primary testicular diffuse large B-cell lymphoma (PT-DLBCL) remains unclear. This study aimed to investigate the 5-hmC expressio...
Autores principales: | Shen, Ye, Wang, Lihong, Ou, Jinping, Wang, Bingjie, Cen, Xinan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8795795/ https://www.ncbi.nlm.nih.gov/pubmed/35165508 http://dx.doi.org/10.7150/ijms.65517 |
Ejemplares similares
-
Influence of Severe Gastrointestinal Complications in Primary Gastrointestinal Diffuse Large B-Cell Lymphoma
por: Shen, Ye, et al.
Publicado: (2021) -
5-Hydroxymethylation alterations in cell-free DNA reflect molecular distinctions of diffuse large B cell lymphoma at different primary sites
por: Shen, Ye, et al.
Publicado: (2022) -
5-hydroxymethylcytosine loss is associated with poor prognosis for patients with WHO grade II diffuse astrocytomas
por: Zhang, Feng, et al.
Publicado: (2016) -
Treatment Strategies and Prognostic Factors of Primary Gastric Diffuse Large B Cell Lymphoma: A Retrospective Multicenter Study of 272 Cases from the China Lymphoma Patient Registry
por: Yang, Haiyan, et al.
Publicado: (2019) -
TBL1XR1 mutation predicts poor outcome in primary testicular diffuse large B-cell lymphoma patients
por: Wang, Xinfeng, et al.
Publicado: (2020)